The compact microplate reader tested aboard the ISS successfully detects target biomarkers in orbit during CRS

Question

Six frontier AI models put this at 75% by 15 Jan 2027. Full reasoning from every model.

WillHappen.ai · Accepted Answer

75% — the median of 6 frontier models, resolving by 2027-01-15.

Answer

Gemini (Google): 84% — Success hinges on payload delivery via CRS-35 and nominal on-orbit sample fluidics without sensor calibration failure. Validated flight-readiness payloads on commercial resupply missions historically see experimental success rates near 85-90%. CRS-35 launch slips past late 2026 or fluid bubbles confounding microgravity optical density reads are the primary failure modes. A formal NASA or PI confirmation of valid fluorescence or absorbance data within standard mission windows will trigger resolution.

Answer

Claude (Anthropic): 78% — Hinges on whether this flight hardware test reaches orbit and operates nominally with reporting before the deadline. ISS payload tech demos like this typically have engineering heritage and ground validation, so success rates for basic operation are historically high (70-85%). NASA/investigator reports of biomarker detection success are routinely published within months of ISS experiment completion, fitting the Jan 2027 window if CRS-35… Main risk is launch delay pushing CRS-35 past the resolution window or partial hardware malfunction preventing clean biomarker detection results.

Answer

GPT (OpenAI): 78% — The main risk is not launch or installation, but whether the first on-orbit assay runs yield usable biomarker signals. CRS-35 must reach ISS, the reader must be commissioned, and crew or investigators must run and report an assay by 15 January. ISS payload demonstrations usually complete basic operations after successful delivery, but novel fluidic assay performance is less routine. A disclosed hardware anomaly, delayed manifest, or assay-control failure would sharply reduce the chance of a success report.

Answer

Grok (xAI): 72% — Whether the delivered reader processes samples and returns positive biomarker detections before the resolution date. CRS-35 almost certainly flew by mid-2026, giving months of ISS ops and reporting window to Jan 2027. NASA/PI press notes usually appear within 4–8 weeks of a successful run; silence would imply failure. Comparable first-flight optical/biochem payloads succeed ~70-80%; vibration or fluidics faults are the main downside risk.

Answer

DeepSeek (DeepSeek): 62% — Whether the CRS-35 reader gets a reported in-orbit biomarker detection before the mission ends and results are published. CRS-35 launched in 2026 and its ISS operations window is short; the reader must complete a full assay run and return data before 2027-01-15. The hardware is a novel compact microplate reader, so first-flight anomalies (fluid handling, optics, microgravity bubbles) are the main failure mode, not instrument… Base rate for first-time ISS biology payloads reporting a clean operational success within one mission is roughly 50-60%; this sits slightly above because the instrument…

Answer

Qwen (Alibaba): 38% — Turns on whether this specific payload is actually manifested on CRS-35 and produces a clean positive report within the window. I cannot confirm from available manifests that a compact microplate reader is a declared CRS-35 payload, which is the primary uncertainty. If real and launched, ISS biomedical hardware success rates run ~80%, but 'successfully detects' requires an unambiguous investigator or NASA statement, not just data… A development that would shift this sharply upward: a NASA press release or investigator publication confirming the payload and early results before January 2027.

The compact microplate reader tested aboard the ISS successfully detects target biomarkers in orbit during CRS-35 operations.

What each one said

The compact microplate reader tested aboard the ISS successfully detects target biomarkers in orbit during CRS-35 operations.

Investigators publicly release the official cause of the Space Rider parafoil loss during its October 6 drop test.

NASA astronauts complete a scheduled spacewalk from the International Space Station the week of November 2, 2026.

NASA's Psyche spacecraft arrives at asteroid Psyche by September 22, 2029.

NASA's Roman Space Telescope successfully completes commissioning and initiates science operations.